Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LivaNova PLC (LIVN : NSDQ)

• Company Description    LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. Number of Employees: 2,900

• Price / Volume Information    Yesterday's Closing Price: $56.22 Daily Weekly Monthly 20 Day Moving Average: 563,145 shares Shares Outstanding: 54.60 (millions) Market Capitalization: $3,069.67 (millions) Beta: 0.97 52 Week High: $58.91 52 Week Low: $32.48 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.86% 2.04% 12 Week 24.46% 13.06% Year To Date 21.40% 10.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 20 EASTBOURNE TERRACE - LONDON,X0 W2 6LG GBR ph: 44-0-20-3325-0660 fax: 281-218-9332 investorrelations@livanova.com http://www.livanova.com

• General Corporate Information    Officers Vladimir Makatsaria - Chief Executive Officer and Director William A. Kozy - Chair of the Board Alex Shvartsburg - Chief Financial Officer J. Christopher Barry - Director Francesco Bianchi - Director Peer Information LivaNova PLC (ABMD) LivaNova PLC (DMDS) LivaNova PLC (CPWY.) LivaNova PLC (EQUR) LivaNova PLC (ECIA) LivaNova PLC (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: G5509L101 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 10/29/25 Share - Related Items Shares Outstanding: 54.60 Most Recent Split Date: (:1) Beta: 0.97 Market Capitalization: $3,069.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.78 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.22 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/29/25

• Fundamental Ratios P/E Current FY Estimate: 17.48 Trailing 12 Months: 17.57 PEG Ratio: - Price Ratios Price/Book: 2.73 Price/Cash Flow: 13.26 Price / Sales: 2.34 EPS Growth vs. Year Ago Period: 14.81% vs. Previous Quarter: 19.23% Sales Growth vs. Year Ago Period: 10.64% vs. Previous Quarter: 11.23% ROE 06/30/25 - 14.57 03/31/25 - 13.67 12/31/24 - 13.02 ROA 06/30/25 - 6.91 03/31/25 - 6.68 12/31/24 - 6.67 Current Ratio 06/30/25 - 1.29 03/31/25 - 1.58 12/31/24 - 2.87 Quick Ratio 06/30/25 - 1.09 03/31/25 - 1.37 12/31/24 - 2.50 Operating Margin 06/30/25 - 13.32 03/31/25 - 13.15 12/31/24 - 13.23 Net Margin 06/30/25 - -16.13 03/31/25 - -17.41 12/31/24 - 5.05 Pre-Tax Margin 06/30/25 - -13.85 03/31/25 - -15.14 12/31/24 - 7.05 Book Value 06/30/25 - 20.56 03/31/25 - 18.97 12/31/24 - 24.31 Inventory Turnover 06/30/25 - 2.55 03/31/25 - 2.53 12/31/24 - 2.48 Debt-to-Equity 06/30/25 - 0.31 03/31/25 - 0.53 12/31/24 - 0.42 Debt-to-Capital 06/30/25 - 23.68 03/31/25 - 34.68 12/31/24 - 29.39

Powered by Zacks Investment Research ©